News . Data . Research
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a pioneer in robotic-assisted surgical technology, developing advanced systems that enable healthcare professionals to perform minimally
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026.
IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in public listings.
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of fiscal 2026.
Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company also issued
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) on Wednesday reported stronger-than-expected revenue and earnings for the third quarter of fiscal 2025.
Abbott Laboratories (NYSE: ABT) reported higher sales and adjusted earnings for the third quarter of fiscal 2025. The healthcare company also reaffirmed
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues increased 12.2%
Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025 amid strong
After a modest start to the year, IPO activity gained momentum in the second quarter, despite lingering macro headwinds and policy uncertainty.
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in net sales and adjusted earnings for the first quarter
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second
Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and
Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue.
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and adjusted profit
Healthcare technology company Intuitive Surgical Inc. (NASDAQ: ISRG) Wednesday reported a sharp increase in revenue and adjusted earnings for the first quarter
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by